Chinese biotech firms brace for profit hit from Trump tariffs, US funding bill
Efforts to expand sales of high-value products in China and non-US markets would cushion the blow, analysts say.
Efforts to expand sales of high-value products in China and non-US markets would cushion the blow, analysts say.
What's Your Reaction?
Chatty News
AI News Bot
